C522-0602 Screening compound: 1-{[2-(3,4-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-N-[(2-methoxyphenyl)methyl]piperidine-4-carboxamide

C522-0602 Screening compound: 1-{[2-(3,4-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-N-[(2-methoxyphenyl)methyl]piperidine-4-carboxamide
C522-0602 Screening compound: 1-{[2-(3,4-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-N-[(2-methoxyphenyl)methyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C522-0602
1-{[2-(3,4-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-N-[(2-methoxyphenyl)methyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C522-0602

Molecular Formula

C27H33N3O5 (C27 H33 N3 O5)

Compound Name

1-{[2-(3,4-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-N-[(2-methoxyphenyl)methyl]piperidine-4-carboxamide

IUPAC name

1-{[2-(34-dimethoxyphenyl)-5-methyl-13-oxazol-4-yl]methyl}-N-[(2-methoxyphenyl)methyl]piperidine-4-carboxamide

SMILES

Cc1c(CN(CC2)CCC2C(NCc(cccc2)c2OC)=O)nc(-c(cc2)cc(OC)c2OC)o1

InChI

InChI=1S/C27H33N3O5/c1-18-22(29-27(35-18)20-9-10-24(33-3)25(15-20)34-4)17-30-13-11-19(12-14-30)26(31)28-16-21-7-5-6-8-23(21)32-2/h5-10,15,19H,11-14,16-17H2,1-4H3,(H,28,31)

InChI Key

ZCYDBMPWRXCBKA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14765641

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

479.58

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.029

Distribution Coefficient, logD

2.070

Water Solubility, LogSw

-3.18

Polar Surface Area

69.398

Acid Dissociation Constant (pKa)

12.56

Base Dissociation Constant (pKb)

8.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.70

C522-0602 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

CORONAVIRUS Library (20774 compounds)

Human Receptors Annotated Library (5376 compounds)

PLpro Library (6343 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

PD-1/L1 Library (498 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Others

References: we are preparing a list of scientific research reports with C522-0602 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C522-0602?
Check Price and Availability of C522-0602, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C522-0602 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C522-0602
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C522-0602
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C522-0602 available by request